FDA Perpetuates Failed Strategy in Latest VRBPAC Meeting on Flu Shots

You’ve heard the saying: Insanity is repeating the same failed actions in the expectation of different results. Once again, the FDA is exemplifying this pattern of human folly with its latest round of flu shots. Once again, we are fighting back through our attorneys with a recent letter to VRBPAC and the FDA.

Last year, on March 5, 2021, the FDA convened its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss the formulation of influenza vaccines for the 2021/2022 season. And, true to form, it rubber-stamped the one-size-fits-all recommendations of the World Health Organization.

But, according to the FDA’s own recent findings, this concoction proved, according to its own data, to be only 8% effective against influenza A and 14% effective against influenza A/H3N2. The analysis even included the possibility ofnegative efficacy against both of these strains!  Meaning it is possible it made those that got the shot more likely to have the flu.  The FDA also looked at an influenza outbreak at a large university campus in the fall of 2021, where the vaccine’s effectiveness proved to be zero!

So, did the FDA learn from its mistakes, go back to the drawing board, and revise its methodology? Not one bit! When the committee met again for four hours on March 3, 2022 to prepare for the 2022/2023 influenza season, it replicated the same broken process all over again!

And the insanity walked hand in hand with its close cousin, ignorance. At VRBPAC’s most recent meeting, committee member Dr. David Wentworth stated, “There is no such thing as negative VE [vaccine efficacy].” But a large body of literature shows that some vaccines do indeed lead to more cases of the ailment they are supposed to mitigate and to worse outcomes than not vaccinating at all. This happens in part through “antibody-dependent enhancement.”

Perhaps unsurprisingly, there was no discussion of adverse events in the latest meeting. This prompted ICAN, through its attorneys, to send a letter to VRBPAC and the FDA.  In it, we note that the flu shots contain squalene oil which is “linked with a wide range of adverse effects including autoimmunity.” Taking all this into account, the committee’s recommendations “will likely leave patients worse off, which is a violation of your duty of care.”

Though we have learned to laugh at the absurdities enthroned in government, these particular absurdities do not fold away with the theater in which they’re played because, as we told the FDA, “many institutions convert your recommendations into rights-crushing and informed-consent-eliminating mandates.” The letter concludes: “The American people deserve better” and notes that the FDA has “a duty of care to remove approval and recommendation for this product.”

One wonders what cognitive dissonance is at work when the vaccine committee meets, what elephants in the room are being ignored, what financial incentives are in play. The FDA has already inflicted irreparable damage to public trust in recent years, yet it seems as determined as ever to squander what little credibility it has left. As we have seen, viruses are agile and mutable. The FDA is neither.